Free Cash Flow Chart

View Free Cash Flow for CBSC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Free Cash Flow Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -0.6874M
March 31, 2026 -0.6367M
December 31, 2025
September 30, 2025
June 30, 2025
March 31, 2025
December 31, 2024 -1.056M
September 30, 2024 -0.9749M
June 30, 2024 -1.16M
March 31, 2024 -1.245M
December 31, 2023 -0.8608M
September 30, 2023 -1.028M
June 30, 2023 -1.074M
March 31, 2023 -1.187M
December 31, 2022 12.49M
September 30, 2022 12.50M
June 30, 2022 12.78M
March 31, 2022 12.99M
December 31, 2021 -0.8886M
Date Value
September 30, 2021 -0.7046M
June 30, 2021 -0.4845M
March 31, 2021 -0.6626M
December 31, 2020 -0.9491M
September 30, 2020
June 30, 2020
March 31, 2020
December 31, 2019
June 30, 2019 -0.1777M
March 31, 2019 -0.1087M
December 31, 2018 -0.5896M
September 30, 2018 -0.7853M
June 30, 2018 -0.7001M
March 31, 2018 -0.7751M
December 31, 2017 -0.2039M
September 30, 2017 -0.0727M
June 30, 2017 -0.0568M
March 31, 2017 -0.0625M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Vyome Holdings, Inc. 0.5245M
Abbott Laboratories 7.824B
AngioDynamics, Inc. -2.86M
Alphatec Holdings, Inc. -5.739M
AtriCure, Inc. 53.11M